[Efficacy of Prostat in the treatment of NIH category IIIA prostatitis].
OBJECTIVE
To evaluate the efficacy of Prostat in the treatment of NIH category IIIA prostatitis.


METHODS
An open clinical trial was conducted among 106 NIH category IIIA prostatitis patients. For each patient 1 tablet of Prostat (70 mg P5 + 4 mg EA10) was orally administered twice a day.


RESULTS
Subjective symptoms of the patients were significantly improved, particularly those of frequent micturition, urgent urination and peripheral region pains. Objective parameters also showed significant improvement. No adverse reaction associated with the medication was observed.


CONCLUSIONS
Prostat was shown to be an appropriate medicine in the treatment of NIH category IIIA prostatitis, with good curative effect and high safety.
Yan
Hongtao
H
Department of Urology, the People's Hospital of Sichuan Province, Chengdu, Sichuan 610072, China.
Liao
Yong
Y
Gong
Baisheng
B
Chen
Zhaoxiang
Z
D000328:Adult; D006801:Humans; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D011058:Pollen; D011472:Prostatitis / Q000188:drug therapy*; D016896:Treatment Outcome